Haas, N.B.; Shevach, J.; Davis, I.D.; Eisen, T.; Gross-Goupil, M.; Kapoor, A.; Master, V.A.; Ryan, C.W.; Schmidinger, M.
2022 WUOF/SIU International Consultation on Urological Diseases: Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma. Soc. Int. Urol. J. 2022, 3, 464-476.
https://doi.org/10.48083/VSQG7437
AMA Style
Haas NB, Shevach J, Davis ID, Eisen T, Gross-Goupil M, Kapoor A, Master VA, Ryan CW, Schmidinger M.
2022 WUOF/SIU International Consultation on Urological Diseases: Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma. Société Internationale d’Urologie Journal. 2022; 3(6):464-476.
https://doi.org/10.48083/VSQG7437
Chicago/Turabian Style
Haas, Naomi B., Jeffrey Shevach, Ian D. Davis, Tim Eisen, Marine Gross-Goupil, Anil Kapoor, Viraj A. Master, Christopher W. Ryan, and Manuela Schmidinger.
2022. "2022 WUOF/SIU International Consultation on Urological Diseases: Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma" Société Internationale d’Urologie Journal 3, no. 6: 464-476.
https://doi.org/10.48083/VSQG7437
APA Style
Haas, N. B., Shevach, J., Davis, I. D., Eisen, T., Gross-Goupil, M., Kapoor, A., Master, V. A., Ryan, C. W., & Schmidinger, M.
(2022). 2022 WUOF/SIU International Consultation on Urological Diseases: Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma. Société Internationale d’Urologie Journal, 3(6), 464-476.
https://doi.org/10.48083/VSQG7437
